Home LiteratureArticle Details
PMID: 15166270 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma.

Journal of clinical pathology ·Vol. 57 ·No. 6 ·2004-06-00 ·Pages 630-6

Esposito I, Menicagli M, Funel N, Bergmann F, Boggi U, Mosca F, Bevilacqua G, Campani D

Abstract

Inflammatory cells contribute to the growth and spread of human malignancies by producing molecules that enhance tumour invasiveness. To characterise the inflammatory infiltrate in pancreatic ductal adenocarcinoma and to analyse its contribution to angiogenesis and its prognostic relevance. Immunohistochemistry was used to identify inflammatory cells and evaluate the expression of proangiogenic and prolymphangiogenic molecules (vascular endothelial growth factor A (VEGF-A), VEGF-C, and basic fibroblast growth factor (bFGF)) by inflammatory and cancer cells in 137 pancreatic cancers. Intratumorous microvessel density (IMD) was assessed using CD34 as an endothelial cell marker. There were significantly more mast cells and macrophages in pancreatic cancers than in normal pancreas and the number of mast cells directly correlated with the presence of lymph node metastases. However, there was no relation between numbers of infiltrating inflammatory cells and the presence of chronic pancreatitis (CP)-like changes in the parenchyma surrounding the tumour. Double immunostaining revealed that both pancreatic mast cells and macrophages express VEGF-A, VEGF-C, and bFGF. These factors were also expressed in the tumour cells in many cases. The numbers of VEGF-A expressing tumour cells and bFGF expressing tumour and inflammatory cells significantly correlated with IMD. Moreover, tumours with higher IMD had higher numbers of infiltrating mast cells and macrophages. Mononuclear inflammatory cells of the non-specific immune response are recruited to pancreatic cancer tissues independent of the presence of CP-like changes, may influence the metastatic capacity of the cancer cells, and may contribute to the development of tumours with high angiogenic activity.

MeSH Terms
Adult Aged Aged, 80 and over Carcinoma, Pancreatic Ductal/blood supply,metabolism,pathology,secondary Female Fibroblast Growth Factor 2/metabolism Humans Inflammation/pathology Lymphatic Metastasis Macrophages/metabolism,pathology Male Mast Cells/metabolism,pathology Middle Aged Neoplasm Proteins/metabolism Neoplasm Staging Neovascularization, Pathologic/metabolism,pathology Pancreas/metabolism Pancreatic Neoplasms/blood supply,metabolism,pathology Survival Analysis Vascular Endothelial Growth Factor A/metabolism Vascular Endothelial Growth Factor C/metabolism
Chemicals
Neoplasm Proteins VEGFA protein, human VEGFC protein, human Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factor C Fibroblast Growth Factor 2
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Esposito I
Institute of Pathology, University of Heidelberg, 69120 Heidelberg, Germany. irene_esposito@med.uni-heidelberg.de
Menicagli M
Funel N
Bergmann F
Boggi U
Mosca F
Bevilacqua G
Campani D
References (48)
48 references, click to expand
  1. Angiogenesis in pancreatic carcinoma: thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predictors of overall and relapse-free survival.
    Cancer. 2001 Oct 1;92(7):1788-97 PMID: 11745251
  2. Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development.
    Breast Cancer Res. 2002;4(4):155-64 PMID: 12100741
  3. The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus.
    J Clin Pathol. 2001 Dec;54(12):940-4 PMID: 11729214
  4. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression.
    Clin Cancer Res. 1997 Aug;3(8):1309-16 PMID: 9815813
  5. Cancer immunoediting: from immunosurveillance to tumor escape.
    Nat Immunol. 2002 Nov;3(11):991-8 PMID: 12407406
  6. Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer.
    Pancreas. 2001 Apr;22(3):285-92 PMID: 11291931
  7. Molecular mechanisms in chronic pancreatitis.
    Zentralbl Chir. 2001 Nov;126(11):867-72 PMID: 11753795
  8. Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer.
    Int J Cancer. 1999 May 17;81(4):650-7 PMID: 10225458
  9. The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix.
    J Histochem Cytochem. 2001 Aug;49(8):1061-2 PMID: 11457936
  10. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha.
    Nature. 1987 Oct 15-21;329(6140):630-2 PMID: 2443857
  11. Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma.
    Virchows Arch. 2002 Jun;440(6):583-8 PMID: 12070596
  12. Angiogenic factors stimulate mast-cell migration.
    Blood. 1995 Oct 1;86(7):2488-93 PMID: 7545457
  13. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies.
    J Pathol. 2002 Mar;196(3):254-65 PMID: 11857487
  14. Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers.
    Cancer Res. 2001 Mar 1;61(5):1833-8 PMID: 11280733
  15. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma.
    Am J Pathol. 2001 Sep;159(3):893-903 PMID: 11549582
  16. Expression of basic fibroblast growth factor and its receptor by fibroblast, macrophages and mast cells in hypertrophic scar.
    Eur J Dermatol. 1999 Jul-Aug;9(5):357-62 PMID: 10417437
  17. Principles of tumor immunosurveillance and implications for immunotherapy.
    Cancer Gene Ther. 2002 Dec;9(12):1043-55 PMID: 12522443
  18. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor.
    J Clin Invest. 1997 Jun 1;99(11):2691-700 PMID: 9169499
  19. Growth factors in pancreatic health and disease.
    Pancreatology. 2001;1(4):343-55 PMID: 12120213
  20. The role of mast cells in tumour angiogenesis.
    Br J Haematol. 2001 Dec;115(3):514-21 PMID: 11736931
  21. Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206.
    Mol Biol Cell. 1998 Apr;9(4):875-84 PMID: 9529385
  22. Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma.
    Eur J Clin Invest. 2003 May;33(5):420-5 PMID: 12760367
  23. Mast cell infiltration around gastric cancer cells correlates with tumor angiogenesis and metastasis.
    Gastric Cancer. 1999 May;2(1):26-32 PMID: 11957067
  24. Mast cell distribution and activation in chronic pancreatitis.
    Hum Pathol. 2001 Nov;32(11):1174-83 PMID: 11727255
  25. Human mast cells produce IL-8.
    J Immunol. 1993 Sep 15;151(6):3261-6 PMID: 8376778
  26. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.
    Nat Med. 2001 Feb;7(2):192-8 PMID: 11175850
  27. Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma.
    Cancer. 2000 Jun 15;88(12):2686-92 PMID: 10870050
  28. Heparan sulfate proteoglycan isoforms of the CD44 hyaluronan receptor induced in human inflammatory macrophages can function as paracrine regulators of fibroblast growth factor action.
    J Biol Chem. 2000 Mar 17;275(11):7964-74 PMID: 10713114
  29. Chymase mediates mast cell-induced angiogenesis in hamster sponge granulomas.
    Eur J Pharmacol. 2000 Aug 18;402(1-2):181-91 PMID: 10940372
  30. Inflammation and the development of pancreatic cancer.
    Surg Oncol. 2002 May;10(4):153-69 PMID: 12020670
  31. Biotherapeutic approaches to pancreatic cancer.
    Expert Opin Biol Ther. 2003 Apr;3(2):319-37 PMID: 12662145
  32. Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neoplastic cells at the site of primary invasion.
    Am J Pathol. 2002 Jan;160(1):91-9 PMID: 11786403
  33. Prognostic significance of angiogenesis in human pancreatic cancer.
    Br J Cancer. 1999 Mar;79(9-10):1553-63 PMID: 10188906
  34. Pattern of distribution and prognostic value of angiogenesis in pancreatic duct carcinoma: a semiquantitative immunohistochemical study of 45 patients.
    Pancreas. 2001 Apr;22(3):240-7 PMID: 11291924
  35. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis.
    Am J Pathol. 2002 Sep;161(3):947-56 PMID: 12213723
  36. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage.
    Cancer Res. 1993 Nov 1;53(21):5289-96 PMID: 7693336
  37. The medical management of pancreatic cancer: a review.
    Oncologist. 2003;8(2):149-60 PMID: 12697940
  38. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells.
    J Biol Chem. 1995 Mar 3;270(9):4689-96 PMID: 7876240
  39. Thymidine phosphorylase expression in tumor-infiltrating macrophages may be correlated with poor prognosis in uterine endometrial cancer.
    Hum Pathol. 2002 Nov;33(11):1105-13 PMID: 12454815
  40. Prognostic significance of intratumoural microvessel density (IMD) in resected pancreatic and ampullary cancers to standard histopathological variables and survival.
    Eur J Surg Oncol. 2002 Sep;28(6):637-44 PMID: 12359201
  41. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas.
    Int J Cancer. 2002 Nov 20;102(3):220-4 PMID: 12397639
  42. Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma.
    Eur Respir J. 2000 Jun;15(6):1087-93 PMID: 10885428
  43. The stem cell factor-c-kit system and mast cells in human pancreatic cancer.
    Lab Invest. 2002 Nov;82(11):1481-92 PMID: 12429808
  44. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy.
    J Exp Med. 2001 Mar 19;193(6):727-40 PMID: 11257139
  45. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.
    Clin Cancer Res. 2003 Feb;9(2):729-37 PMID: 12576442
  46. Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis.
    Eur J Cancer. 1998 Aug;34(9):1439-47 PMID: 9849429
  47. Growth factors and epithelial-stromal interactions in prostate cancer development.
    Int Rev Cytol. 2000;199:65-116 PMID: 10874577
  48. Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process.
    Cancer Res. 2002 Dec 1;62(23):7042-9 PMID: 12460925
Article Info
Journal
Journal of clinical pathology
Abbr.
J Clin Pathol
ISSN
0021-9746
Published
2004-06-00
Pages
630-6
Language
English
Region
England
NLM ID
0376601
PMCID
PMC1770337
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com